Smithfield Trust CO Mannkind Corp Transaction History
Smithfield Trust CO
- $2.04 Billion
- Q3 2024
A detailed history of Smithfield Trust CO transactions in Mannkind Corp stock. As of the latest transaction made, Smithfield Trust CO holds 5,000 shares of MNKD stock, worth $35,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$35,100
Previous $26,000
19.23%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MNKD
# of Institutions
245Shares Held
148MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$158 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$67.4 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$64.3 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$61.4 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.81B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...